IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -3.93%50.980.0%$769.32m
GWPHGW Pharmaceuticals Plc 0.06%215.146.1%$387.15m
HZNPHorizon Therapeutics Plc -4.60%91.095.6%$194.39m
JAZZJazz Pharmaceuticals Plc -1.09%171.612.3%$186.40m
VRXValeant Pharmaceuticals International, Inc. 0.71%31.2714.1%$184.00m
BHCBausch Health Cos., Inc. 0.52%31.210.0%$141.94m
CTLTCatalent, Inc. -2.13%112.702.1%$111.32m
ARGXargenx SE 0.50%338.570.0%$83.26m
ICLRICON plc -3.62%185.454.2%$76.48m
TNXPTonix Pharmaceuticals Holding Corp. -0.80%1.240.2%$71.02m
ZYNEZynerba Pharmaceuticals, Inc. -8.61%4.586.0%$59.64m
AMRNAmarin Corp. Plc -3.01%7.081.5%$55.68m
PRGOPerrigo Co. Plc -2.09%40.796.8%$51.17m
PBHPrestige Consumer Healthcare, Inc. -0.26%41.964.0%$48.24m
UTHRUnited Therapeutics Corp. -1.71%170.7314.1%$45.32m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.